Cure Fund Challenge


The Cure Starts Now Foundation offers a $50,000 (U.S. dollars) start-up grant awarded to an innovative grant related to pediatric brain cancer research. Such approved grant is expected to be implemented within 6-months of acceptance and no grant shall be contingent on other external funding unless explicitly approved in writing by the Chairman of the Medical Advisory Council of CSN. Considerations will be made for multiple grant solicitations that represent separate expense line items or an expansion of an existing research project with the prior approval of the Chairman of the Medical Advisory Council of The Cure Starts Now.

Funding is for direct costs related to the research project. Examples of direct costs include personnel, salary, supplies, equipment and patient care expenses. Support for salary must not exceed percentage of effort related to the research. Institutional costs may be considered, but it is recommended that justification be provided in the budget of the grant. A total of 10% or less of institutional and indirect costs is recommended. Travel costs are excluded from funding in this grant application, but investigators may request additional support from The Cure Starts Now to travel to meetings to present research funded by the Foundation. These requests will be considered on a case-by-case basis.


  • Must be an MD, DO, PhD, DrPH or equivalent
  • Must be a member of a non-profit organization or a valid medical/scientific organization.
  • Must be up to date with any previous funding through The Cure Starts Now, which includes progress report submissions.

How to Apply

  • Applications must be submitted as a researcher account within the system.
  • Grants must be assigned the “ISPNO Cure Fund” affiliation when posting within
  • Submit preliminary grant applications by May 18, 2018 at 11:00pm EST


  • Single spaced
  • 12 point font
  • In English
  • Page size: 8.5 x 11 inches


Grant applications will be assessed based on the following criteria:

  • Innovation (a primary consideration of the Snap Grant process and may be weighted accordingly)
    Does the research study propose a novel approach or represent advancement in current treatment of pediatric brain cancer?
  • Scientific merit
    What is the hypothesis and does the study adequately answer and address the hypothesis? Does the study use valid research and statistical methods?
  • Disease impact
    Does the study propose an intervention or clinical tool that will reduce the morbidity or mortality from or potentially find a cure for pediatric brain cancer?
  • Feasibility
    Is the study likely to meet its goals during the funding period? Can the research findings be translated into clinic practice? Are the research findings likely to result in a direct change in morbidity or mortality of pediatric brain cancer in the near future?
  • Expertise of investigator(s)
    Do the investigators have the expertise to meet their research goals?


If you have questions or need assistance, please contact Keith Desserich at: